Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 44
Filtrar
1.
Genet Med ; 26(4): 101059, 2024 04.
Artigo em Inglês | MEDLINE | ID: mdl-38158857

RESUMO

PURPOSE: Oral-facial-digital (OFD) syndromes are genetically heterogeneous developmental disorders, caused by pathogenic variants in genes involved in primary cilia formation and function. We identified a previously undescribed type of OFD with brain anomalies, ranging from alobar holoprosencephaly to pituitary anomalies, in 6 unrelated families. METHODS: Exome sequencing of affected probands was supplemented with alternative splicing analysis in patient and control lymphoblastoid and fibroblast cell lines, and primary cilia structure analysis in patient fibroblasts. RESULTS: In 1 family with 2 affected males, we identified a germline variant in the last exon of ZRSR2, NM_005089.4:c.1211_1212del NP_005080.1:p.(Gly404GlufsTer23), whereas 7 affected males from 5 unrelated families were hemizygous for the ZRSR2 variant NM_005089.4:c.1207_1208del NP_005080.1:p.(Arg403GlyfsTer24), either occurring de novo or inherited in an X-linked recessive pattern. ZRSR2, located on chromosome Xp22.2, encodes a splicing factor of the minor spliceosome complex, which recognizes minor introns, representing 0.35% of human introns. Patient samples showed significant enrichment of minor intron retention. Among differentially spliced targets are ciliopathy-related genes, such as TMEM107 and CIBAR1. Primary fibroblasts containing the NM_005089.4:c.1207_1208del ZRSR2 variant had abnormally elongated cilia, confirming an association between defective U12-type intron splicing, OFD and abnormal primary cilia formation. CONCLUSION: We introduce a novel type of OFD associated with elongated cilia and differential splicing of minor intron-containing genes due to germline variation in ZRSR2.


Assuntos
Processamento Alternativo , Síndromes Orofaciodigitais , Masculino , Humanos , Processamento Alternativo/genética , Síndromes Orofaciodigitais/genética , Splicing de RNA , Íntrons , Spliceossomos/genética , Ribonucleoproteínas/genética
2.
Horm Metab Res ; 52(6): 412-420, 2020 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-32215882

RESUMO

Mast cells are immune cells present in adrenals from various species. Proliferation and activation of adrenal mast cells seem to be influenced by environment, since they increase during summer and in response to sodium restriction in frogs and mouse, respectively. Although the physiological factors regulating adrenal mast cell activity have not been identified, they might involve neurotransmitters and the renin-angiotensin system. Some data indicate that adrenal mast cells stimulate proliferation of steroidogenic cells in the zona glomerulosa and activate the mineralocorticoid production. In human, mast cell degranulation stimulates aldosterone synthesis through the release of serotonin (5-HT) and activation of 5-HT4 receptors. Increase in mast cell population and upregulation of the 5-HT signaling pathway occur in aldosterone-producing adenomas. In particular, aldosterone-producing adenoma cells overexpress 5-HT4 receptors and are hyper-responsive to 5-HT4 receptor agonists. These data suggest that the intra-adrenal serotonergic regulatory system represents a potential target for development of both adrenal imaging methods to evaluate the lateralization of aldosterone production, and pharmacological treatments of primary aldosteronism.


Assuntos
Aldosterona/metabolismo , Mastócitos/fisiologia , Animais , Anuros , Humanos , Camundongos , Via Secretória
3.
J Med Genet ; 55(4): 278-284, 2018 04.
Artigo em Inglês | MEDLINE | ID: mdl-29358272

RESUMO

BACKGROUND: Stüve-Wiedemann syndrome (SWS) is characterised by bowing of the lower limbs, respiratory distress and hyperthermia that are often responsible for early death. Survivors develop progressive scoliosis and spontaneous fractures. We previously identified LIFR mutations in most SWS cases, but absence of LIFR pathogenic changes in five patients led us to perform exome sequencing and to identify homozygosity for a FAM46A mutation in one case [p.Ser205Tyrfs*13]. The follow-up of this case supported a final diagnosis of osteogenesis imperfecta (OI), based on vertebral collapses and blue sclerae. METHODS AND RESULTS: This prompted us to screen FAM46A in 25 OI patients with no known mutations.We identified a homozygous deleterious variant in FAM46A in two affected sibs with typical OI [p.His127Arg]. Another homozygous variant, [p.Asp231Gly], also classed as deleterious, was detected in a patient with type III OI of consanguineous parents using homozygosity mapping and exome sequencing.FAM46A is a member of the superfamily of nucleotidyltransferase fold proteins but its exact function is presently unknown. Nevertheless, there are lines of evidence pointing to a relevant role of FAM46A in bone development. By RT-PCR analysis, we detected specific expression of FAM46A in human osteoblasts andinterestingly, a nonsense mutation in Fam46a has been recently identified in an ENU-derived (N-ethyl-N-nitrosourea) mouse model characterised by decreased body length, limb, rib, pelvis, and skull deformities and reduced cortical thickness in long bones. CONCLUSION: We conclude that FAM46A mutations are responsible for a severe form of OI with congenital bowing of the lower limbs and suggest screening this gene in unexplained OI forms.


Assuntos
Sequenciamento do Exoma , Osteoblastos/metabolismo , Osteogênese Imperfeita/genética , Proteínas/genética , Animais , Desenvolvimento Ósseo/genética , Osso e Ossos/patologia , Consanguinidade , Feminino , Genes Recessivos/genética , Homozigoto , Humanos , Lactente , Masculino , Camundongos , Mutação , Osteoblastos/patologia , Osteogênese Imperfeita/fisiopatologia , Linhagem , Fenótipo , Polinucleotídeo Adenililtransferase
5.
J Pediatr ; 163(4): 1208-10, 2013 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-23768816

RESUMO

A novel mutation in CYP24A1 provides insight into idiopathic infantile hypercalcemia. In this report of 3 brothers, in twins supplemented with vitamin D (1900 IU/d), only the twin homozygous for CYP24A1 exhibited idiopathic infantile hypercalcemia. A subsequently affected younger brother given vitamin D 400 IU/d was not hypercalcemic.


Assuntos
Suplementos Nutricionais , Hipercalcemia/genética , Doenças do Recém-Nascido/genética , Erros Inatos do Metabolismo/genética , Mutação , Esteroide Hidroxilases/genética , Vitamina D/uso terapêutico , Alelos , Doenças em Gêmeos , Éxons , Feminino , Homozigoto , Humanos , Lactente , Masculino , Hormônio Paratireóideo/metabolismo , Linhagem , Reação em Cadeia da Polimerase/métodos , Análise de Sequência de DNA , Irmãos , Vitamina D3 24-Hidroxilase
6.
Front Pediatr ; 10: 926986, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-36090548

RESUMO

Background: Cinacalcet is a calcimimetic approved in adults with primary hyperparathyroidism (PHPT). Few cases reports described its use in pediatric HPT, with challenges related to the risk of hypocalcemia, increased QT interval and drug interactions. In this study, we report the French experience in this setting. Methods: We retrospectively analyzed data from 18 pediatric patients from 7 tertiary centers who received cinacalcet for PHPT. The results are presented as median (interquartile range). Results: At a median age of 10.8 (2.0-14.4) years, 18 patients received cinacalcet for primary HPT (N = 13 inactive CASR mutation, N = 1 CDC73 mutation, N = 1 multiple endocrine neoplasia type 1, N=3 unknown etiology). Cinacalcet was introduced at an estimated glomerular filtration rate (eGFR) of 120 (111-130) mL/min/1.73 m2, plasma calcium of 3.04 (2.96-3.14) mmol/L, plasma phosphate of 1.1 (1.0-1.3) mmol/L, age-standardized (z score) phosphate of -3.0 (-3.5;-1.9), total ALP of 212 (164-245) UI/L, 25-OHD of 37 (20-46) ng/L, age-standardized (z score) ALP of -2.4 (-3.7;-1.4), PTH of 75 (59-123) ng/L corresponding to 1.2 (1.0-2.3)-time the upper limit for normal (ULN). The starting daily dose of cinacalcet was 0.7 (0.6-1.0) mg/kg, with a maximum dose of 1.0 (0.9-1.4) mg/kg per day. With a follow-up of 2.2 (1.3-4.3) years on cinacalcet therapy, PTH and calcium significantly decreased to 37 (34-54) ng/L, corresponding to 0.8 (0.5-0.8) ULN (p = 0.01), and 2.66 (2.55-2.90) mmol/L (p = 0.002), respectively. In contrast, eGFR, 25-OHD, ALP and phosphate and urinary calcium levels remained stable. Nephrocalcinosis was not reported but one patient displayed nephrolithiasis. Cinacalcet was progressively withdrawn in three patients; no side effects were reported. Conclusions: Cinacalcet in pediatric HPT can control hypercalcemia and PTH without significant side effects.

7.
Hum Mol Genet ; 18(12): 2266-76, 2009 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-19336474

RESUMO

Thyroid transcription factor 1 (NKX2-1/TITF1) mutations cause brain-lung-thyroid syndrome, characterized by congenital hypothyroidism (CH), infant respiratory distress syndrome (IRDS) and benign hereditary chorea (BHC). The objectives of the present study were (i) detection of NKX2-1 mutations in patients with CH associated with pneumopathy and/or BHC, (ii) functional analysis of new mutations in vitro and (iii) description of the phenotypic spectrum of brain-lung-thyroid syndrome. We identified three new heterozygous missense mutations (L176V, P202L, Q210P), a splice site mutation (376-2A-->G), and one deletion of NKX2-1 at 14q13. Functional analysis of the three missense mutations revealed loss of transactivation capacity on the human thyroglobulin enhancer/promoter. Interestingly, we showed that deficient transcriptional activity of NKX2-1-P202L was completely rescued by cotransfected PAX8-WT, whereas the synergistic effect was abolished by L176V and Q210P. The clinical spectrum of 6 own and 40 published patients with NKX2-1 mutations ranged from the complete triad of brain-lung-thyroid syndrome (50%), brain and thyroid disease (30%), to isolated BHC (13%). Thyroid morphology was normal (55%) and compensated hypothyroidism occurred in 61%. Lung disease occurred in 54% of patients (IRDS at term 76%; recurrent pulmonary infections 24%). On follow-up, 20% developed severe chronic interstitial lung disease, and 16% died. In conclusion, we describe five new NKX2.1 mutations with, for the first time, complete rescue by PAX8 of the deficient transactivating capacity in one case. Additionally, our review shows that the majority of affected patients display neurological and/or thyroidal problems and that, although less frequent, lung disease is responsible for a considerable mortality.


Assuntos
Proteínas Nucleares/genética , Fatores de Transcrição Box Pareados/metabolismo , Fatores de Transcrição/genética , Sequência de Bases , Encéfalo/metabolismo , Linhagem Celular , Criança , Pré-Escolar , Estudos de Coortes , Feminino , Humanos , Lactente , Pulmão/metabolismo , Masculino , Dados de Sequência Molecular , Mutação , Proteínas Nucleares/metabolismo , Fator de Transcrição PAX8 , Fatores de Transcrição Box Pareados/genética , Glândula Tireoide/metabolismo , Fator Nuclear 1 de Tireoide , Fatores de Transcrição/metabolismo , Ativação Transcricional
8.
Mol Cell Endocrinol ; 535: 111377, 2021 09 15.
Artigo em Inglês | MEDLINE | ID: mdl-34216641

RESUMO

The human adrenal cortex is a complex organ which is composed of various cell types including not only steroidogenic cells but also mesenchymal cells, immunocompetent cells and neurons. Intermingling of these diverse cell populations favors cell-to-cell communication processes involving local release of numerous bioactive signals such as biogenic amines, cytokines and neuropeptides. The resulting paracrine interactions play an important role in the regulation of adrenocortical cell functions both in physiological and pathophysiological conditions. Especially, recent evidence indicates that adrenocortical cell microenvironment is involved in the pathogenesis of adrenal disorders associated with corticosteroid excess. The paracrine factors involved in these intraadrenal regulatory mechanisms may thus represent valuable targets for future pharmacological treatments of adrenal diseases.


Assuntos
Corticosteroides/metabolismo , Córtex Suprarrenal/metabolismo , Córtex Suprarrenal/patologia , Microambiente Celular , Citocinas/metabolismo , Humanos , Neuropeptídeos/metabolismo , Comunicação Parácrina , Transdução de Sinais
9.
Mol Cell Endocrinol ; 535: 111375, 2021 09 15.
Artigo em Inglês | MEDLINE | ID: mdl-34197901

RESUMO

Sodium and water homeostasis are drastically modified at birth, in mammals, by the transition from aquatic life to terrestrial life. Accumulating evidence during the past ten years underscores the central role for the mineralocorticoid signaling pathway, in the fine regulation of this equilibrium, at this critical period of development. Interestingly, regarding evolution, while the mineralocorticoid receptor is expressed in fish, the appearance of its related ligand, aldosterone, coincides with terrestrial life, as it is first detected in lungfish and amphibian. Thus, aldosterone is likely one of the main hormones regulating the transition from an aquatic environment to an air environment. This review will focus on the different actors of the mineralocorticoid signaling pathway from aldosterone secretion in the adrenal gland, to mineralocorticoid receptor expression in the kidney, summarizing their regulation and roles throughout fetal and neonatal development, in the light of evolution.


Assuntos
Aldosterona/biossíntese , Rim/crescimento & desenvolvimento , Receptores de Mineralocorticoides/metabolismo , Glândulas Suprarrenais/metabolismo , Animais , Regulação da Expressão Gênica no Desenvolvimento , Humanos , Rim/metabolismo , Transdução de Sinais
10.
Hum Mutat ; 31(2): E1146-62, 2010 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-20020530

RESUMO

NKX2-1 (NK2 homeobox 1) is a critical regulator of transcription for the surfactant protein (SP)-B and -C genes (SFTPB and SFTPC, respectively). We identified and functionally characterized two new de novo NKX2-1 mutations c.493C>T (p.R165W) and c.786_787del2 (p.L263fs) in infants with closely similar severe interstitial lung disease (ILD), hypotonia, and congenital hypothyroidism. Functional analyses using A549 and HeLa cells revealed that NKX2-1-p.L263fs induced neither SFTPB nor SFTPC promoter activation and had a dominant negative effect on wild-type (WT) NKX2-1. In contrast,NKX2-1-p.R165W activated SFTPC, to a significantly greater extent than did WTNKX2-1, while SFTPB activation was only significantly reduced in HeLa cells. In accordance with our in vitro data, we found decreased amounts of SP-B and SP-C by western blot in bronchoalveolar lavage fluid (patient with p.L263fs) and features of altered surfactant protein metabolism on lung histology (patient with NKX2-1-p.R165W). In conclusion, ILD in patients with NKX2-1 mutations was associated with altered surfactant protein metabolism, and both gain and loss of function of the mutated NKX2-1 genes on surfactant protein promoters were associated with ILD in "Brain-Lung-Thyroid syndrome".


Assuntos
Anormalidades Múltiplas/genética , Regulação da Expressão Gênica , Doenças Pulmonares Intersticiais/genética , Mutação/genética , Proteínas Nucleares/genética , Regiões Promotoras Genéticas/genética , Proteínas Associadas a Surfactantes Pulmonares/genética , Fatores de Transcrição/genética , Anormalidades Múltiplas/diagnóstico por imagem , Anormalidades Múltiplas/patologia , Sequência de Aminoácidos , Sequência de Bases , Líquido da Lavagem Broncoalveolar , Linhagem Celular Tumoral , Criança , Pré-Escolar , DNA , Evolução Fatal , Feminino , Humanos , Lactente , Recém-Nascido , Doenças Pulmonares Intersticiais/complicações , Doenças Pulmonares Intersticiais/diagnóstico por imagem , Doenças Pulmonares Intersticiais/patologia , Dados de Sequência Molecular , Proteínas Mutantes/química , Proteínas Mutantes/metabolismo , Proteínas Nucleares/química , Proteínas Nucleares/metabolismo , Especificidade de Órgãos/genética , Gravidez , Ligação Proteica , Radiografia , Síndrome , Glândula Tireoide/patologia , Fator Nuclear 1 de Tireoide , Fatores de Transcrição/química , Fatores de Transcrição/metabolismo
11.
Nutrients ; 12(5)2020 May 20.
Artigo em Inglês | MEDLINE | ID: mdl-32443684

RESUMO

BACKGROUND: Post-natal gut maturation in infants interrelates maturation of the morphology, digestive, and immunological functions and gut microbiota development. Here, we explored both microbiota development and markers of gut barrier and maturation in healthy term infants during their early life to assess the interconnection of gut functions during different infant formulae regimes. METHODS: A total of 203 infants were enrolled in this randomized double-blind controlled trial including a breastfed reference group. Infants were fed starter formulae for the first four weeks of life, supplemented with different combination of nutrients (lactoferrin, probiotics (Bifidobacterium animal subsp. Lactis) and prebiotics (Bovine Milk-derived Oligosaccharides-BMOS)) and subsequently fed the control formula up to eight weeks of life. Stool microbiota profiles and biomarkers of early gut maturation, calprotectin (primary outcome), elastase, α-1 antitrypsin (AAT) and neopterin were measured in feces at one, two, four, and eight weeks. RESULTS: Infants fed formula containing BMOS had lower mean calprotectin levels over the first two to four weeks compared to the other formula groups. Elastase and AAT levels were closer to levels observed in breastfed infants. No differences were observed for neopterin. Global differences between the bacterial communities of all groups were assessed by constrained multivariate analysis with hypothesis testing. The canonical correspondence analysis (CCA) at genus level showed overlap between microbiota profiles at one and four weeks of age in the BMOS supplemented formula group with the breastfed reference, dominated by bifidobacteria. Microbiota profiles of all groups at four weeks were significantly associated with the calprotectin levels at 4 (CCA, p = 0.018) and eight weeks of age (CCA, p = 0.026). CONCLUSION: A meaningful correlation was observed between changes in microbiota composition and gut maturation marker calprotectin. The supplementation with BMOS seems to favor gut maturation closer to that of breastfed infants.


Assuntos
Biomarcadores , Suplementos Nutricionais , Microbioma Gastrointestinal/fisiologia , Fórmulas Infantis/análise , Animais , Bifidobacterium animalis , Aleitamento Materno , Método Duplo-Cego , Fezes/microbiologia , Humanos , Lactente , Complexo Antígeno L1 Leucocitário , Leite , Oligossacarídeos/análise , Prebióticos/análise , Probióticos/análise
12.
Paediatr Respir Rev ; 10(3): 134-42, 2009 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-19651384

RESUMO

A high prevalence of low bone mineralization is documented in adult patients with cystic fibrosis (CF). Osteopenia is present in up to 85% of adult patients and osteoporosis in 10% to 34%. In children, study results are discordant probably because of comparisons to different control populations and corrections for bone size in growing children. Malnutrition, inflammation, vitamin D and vitamin K deficiency, altered sex hormone production, glucocorticoid therapy, and physical inactivity are well known risk factors for poor bone health. Puberty is a critical period for bone mineralization and requires a careful follow-up to achieve optimal bone peak mass. Strategies for optimizing bone health, such as monitoring bone mineral density (BMD) and providing preventive care are necessary from childhood through adolescence to minimize CF-related bone disease in adult CF patients.


Assuntos
Doenças Ósseas/etiologia , Fibrose Cística/complicações , Adulto , Densidade Óssea , Remodelação Óssea/fisiologia , Calcificação Fisiológica/fisiologia , Cálcio/metabolismo , Criança , Regulador de Condutância Transmembrana em Fibrose Cística/fisiologia , Humanos , Puberdade/fisiologia , Vitamina K/metabolismo
13.
Vitam Horm ; 109: 303-339, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-30678861

RESUMO

Aldosterone secretion by the zona glomerulosa of the adrenal cortex is controlled by circulating factors including the renin angiotensin system (RAS) and potassium. Mineralocorticoid production is also regulated through an autocrine/paracrine mechanism by a wide variety of bioactive signals released in the vicinity of adrenocortical cells by chromaffin cells, nerve endings, cells of the immune system, endothelial cells and adipocytes. These regulatory factors include conventional neurotransmitters and neuropeptides. Their physiological role in the control of aldosterone secretion is not fully understood, but it is likely that they participate in the RAS-independent regulation of zona glomerulosa cells. Interestingly, recent observations indicate that autocrine/paracrine processes are involved in the pathophysiology of primary aldosteronism. The intraadrenal regulatory systems observed in aldosterone-producing adenomas (APA), although globally similar to those occurring in the normal adrenal gland, harbor alterations at different levels, which tend to strengthen the potency of paracrine signals to activate aldosterone secretion. Enhancement of paracrine stimulatory tone may participate to APA expansion and aldosterone hypersecretion together with somatic mutations of driver genes which activate the calcium signaling pathway and subsequently aldosterone synthase expression. Intraadrenal regulatory mechanisms represent thus promising pharmacological targets for the treatment of primary aldosteronism.


Assuntos
Glândulas Suprarrenais/fisiologia , Aldosterona/metabolismo , Comunicação Parácrina/fisiologia , Glândulas Suprarrenais/citologia , Humanos , Transdução de Sinais
14.
Eur J Med Genet ; 62(11): 103577, 2019 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-30423445

RESUMO

Loss-of-function mutations in CYP24A1 (MIM 126065 20q13.2), the gene encoding the 24-hydroxylase responsible for 25-OH-D and 1,25-(OH)2D degradation, are identified in about 20% of patients presenting Idiopathic Infantile Hypercalcemia (IIH) (MIM 143880). Common features of this autosomal recessive condition included hypercalcemia with hypercalciuria, suppressed PTH and a high 25-OH-D3:24,25-(OH)2D3 ratio. Medical care mainly relies on sun protection and life-long contraindication of vitamin D to avoid complications such as early nephrocalcinosis and renal failure. Molecular diagnosis therefore keeps a crucial place in the diagnosis of IIH, and genetic counseling should be systematically recommended to prevent vitamin D administration in affected siblings. In this report is described the molecular characterization of a CYP24A1 deletion identified in two unrelated families. This highlights the potential role of CYP24A1 copy number variations (CNV) in IIH. Considering the presence of CNV affecting CYP24A1 in public databases, CNV analysis should be systematically added to the sequencing studies in IIH. Targeted Massively Parallel Sequencing (MPS) study coupled with a CNV detection tool called CovCop is a powerful method to detect genic rearrangement and improve genetic analysis.


Assuntos
Hipercalcemia/diagnóstico , Hipercalcemia/genética , Doenças do Recém-Nascido/diagnóstico , Doenças do Recém-Nascido/genética , Erros Inatos do Metabolismo/diagnóstico , Erros Inatos do Metabolismo/genética , Patologia Molecular , Vitamina D3 24-Hidroxilase/genética , Adolescente , Criança , Pré-Escolar , Variações do Número de Cópias de DNA/genética , Feminino , Humanos , Hipercalcemia/tratamento farmacológico , Hipercalcemia/patologia , Lactente , Doenças do Recém-Nascido/tratamento farmacológico , Doenças do Recém-Nascido/patologia , Mutação com Perda de Função/genética , Masculino , Erros Inatos do Metabolismo/tratamento farmacológico , Erros Inatos do Metabolismo/patologia , Nefrocalcinose/tratamento farmacológico , Nefrocalcinose/genética , Nefrocalcinose/prevenção & controle , Insuficiência Renal/tratamento farmacológico , Insuficiência Renal/genética , Insuficiência Renal/prevenção & controle , Deleção de Sequência/genética , Vitamina D/uso terapêutico
15.
J Clin Endocrinol Metab ; 93(10): 3817-26, 2008 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-18628515

RESUMO

CONTEXT: There is debate about how Graves' disease (GD) should be treated in children. OBJECTIVE: The aim of this study was to identify predictors of relapse after antithyroid drug (ATD) treatment in children with GD. STUDY DESIGN AND SETTING: We conducted a prospective, multicenter cohort study of children (n = 154) with GD treated with carbimazole for an intended duration of 24 +/- 3 months. After the end of treatment, patients were followed up for at least 2 yr. The primary outcome was hyperthyroidism relapse. Cox's regression analysis was used and a prognostic score was constructed. RESULTS: The overall estimated relapse rate for hyperthyroidism was 59% (95% confidence interval 52-67%) at 1 yr and 68% (95% confidence interval 60-76%) at 2 yr after the end of treatment. Multivariate survival analysis showed that the risk of relapse was higher for patients of non-Caucasian origin [hazard ratio (HR) = 2.54, P < 0.001], with high serum thyroid-stimulating hormone receptor antibodies (HR = 1.21 by 10 U, P = 0.03) and free T(4) (HR = 1.18 by 10 pmol/liter, P = 0.001) levels at diagnosis. Conversely, relapse risk decreased with increasing age at onset (HR = 0.74 per 5 yr, P = 0.03) and duration of first course of ATD (HR = 0.57 per 12 months, P = 0.005). A prognostic score was constructed, allowing the identification of three different risk groups, with 2-yr relapse rates of 46, 77, and 98%. CONCLUSIONS: A longer initial duration of euthyroid state with ATD seems to be the only variable related to the risk of hyperthyroidism relapse in children that can be manipulated. Ethnic origin, age, and severity of the disease at diagnosis may guide long-term disease management decisions.


Assuntos
Antitireóideos/uso terapêutico , Doenças Autoimunes/diagnóstico , Doenças Autoimunes/tratamento farmacológico , Hipertireoidismo/diagnóstico , Hipertireoidismo/tratamento farmacológico , Suspensão de Tratamento , Adolescente , Algoritmos , Doenças Autoimunes/patologia , Carbimazol/uso terapêutico , Criança , Feminino , Seguimentos , Doença de Graves/diagnóstico , Doença de Graves/tratamento farmacológico , Doença de Graves/patologia , Humanos , Hipertireoidismo/patologia , Masculino , Prognóstico , Recidiva , Fatores de Risco
16.
Horm Res ; 70(4): 240-8, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18772598

RESUMO

AIMS: To describe the phenotype of a large group of children with congenital hypothyroidism (CH) and iodide organification defect (IOD), suspected based on normal thyroid position and abnormal perchlorate discharge test, as first step of a project evaluating correlations between phenotypes and genotypes. METHODS: 71 children born in Paris between 1980 and 2006 were included. Two groups were defined according to perchlorate discharge: total IOD (TIOD) when the release was above 90% and partial IOD (PIOD) between 10 and 90%. Comparisons between groups were performed using SPSS 14.0 for Windows. RESULTS: The incidence of IOD over the 2003-2006 period was 1:20,660. Of the 71 children, 61 had PIOD and 10 TIOD. Compared to PIOD, TIOD was characterized by greater clinical severity. A wide spectrum of clinical features was seen in the PIOD group. Evolution showed transient hypothyroidism in 10/61 patients with PIOD and 1/10 TIOD patients. CONCLUSIONS: Severe presentation in the majority of TIOD patients suggests dysfunction of a key iodide-organification enzyme. In contrast, the variety of clinical features in PIOD group suggests that diverse mechanisms may lead to PIOD, such as delayed or reduced activity of enzymes involved in hormonogenesis or defects in iodine storage and release.


Assuntos
Hipotireoidismo Congênito/enzimologia , Iodetos/metabolismo , Glândula Tireoide/enzimologia , Feminino , Humanos , Lactente , Recém-Nascido , Masculino , Paris , Estudos Retrospectivos
17.
Endocr Dev ; 33: 149-157, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29886483

RESUMO

Spermatozoa have occasionally been identified in ejaculate of adult Klinefelter syndrome (KS) patients but very exceptionally in KS adolescents. Spermatozoa can also be retrieved in testicular tissue of KS adolescents. The testis may also harbor spermatogonia and noncompletely differentiated germ cells. Neither clinical features nor hormonal parameters could predict germ cell recovery in KS adults or adolescents. No predictive factors can actually demonstrate that early diagnosis of KS would allow increasing the chance of sperm retrieval even if it has been suggested that semen quality may decline with age in KS patients. Leydig cell dysfunction may also be another factor that might affect the spermatogenesis process in XXY adolescents. Fertility preservation might be preferentially proposed in KS adolescents when semen sampling is possible, when the patient is able to consider alternative options to become a father, and to accept germ cell retrieval failure. However, precocious diagnosis of KS has also to be considered because it might not solely improve the possibility of fertility preservation after the onset of puberty, but also the medical care and the quality of life of these patients.


Assuntos
Preservação da Fertilidade/métodos , Síndrome de Klinefelter/terapia , Maturidade Sexual/fisiologia , Transição para Assistência do Adulto , Adolescente , Adulto , Humanos , Síndrome de Klinefelter/fisiopatologia , Masculino , Qualidade de Vida , Análise do Sêmen , Recuperação Espermática , Espermatogênese/fisiologia , Transição para Assistência do Adulto/organização & administração , Adulto Jovem
18.
Hum Genet ; 122(5): 467-76, 2007 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-17717707

RESUMO

Familial cases of congenital hypothyroidism from thyroid dysgenesis (TD) (OMIM 218700) occur with a frequency 15-fold higher than by chance, FOXE1 is one of the candidate genes for this genetic predisposition and contains an alanine tract. Our purpose is to assess the influence of length of the alanine tract of FOXE1 on genetic susceptibility to TD. A case-control association study (based on 115 patients affected by TD and 129 controls genotyped by direct sequencing) and transmission disequilibrium testing (TDT) analyses were performed. The transcriptional activities of FOXE1 constructs containing 14 or 16 alanines were also studied. In the case-control association study, the 16/16 and 16/14 genotypes were inversely associated with TD (OR = 0.39, 95%CI = 0.22-0.68, P = 0.0005), strongly suggesting that the presence of 16 alanines in the tract protect against the occurrence of TD. This association was stronger in the subgroup of patients with ectopic thyroid (OR = 0.28, 95%CI = 0.13-0.58, P = 0.00015). The protection was confirmed by the TDT analysis performed in 39 trios (chi(2) = 4.3, P = 0.0374). Alternatively, the presence of the 14/14 genotype is associated with an increase risk of TD (OR = 2.59, 95%CI = 1.56-4.62, P = 0.0005). The expression studies showed that the transcriptional activities of FOXE1 with 16 alanines were significantly higher (1.55-fold) than FOXE1 containing 14 alanines (P < 0.003), while the nuclear localisation of the proteins was not affected. We conclude that FOXE1 through its alanine containing stretch modulates significantly the risk of TD occurrence, enhancing a mechanism linking an alanine containing transcription factor to disease.


Assuntos
Fatores de Transcrição Forkhead/química , Fatores de Transcrição Forkhead/genética , Disgenesia da Tireoide/genética , Sequência de Bases , Estudos de Casos e Controles , Linhagem Celular , Hipotireoidismo Congênito/genética , Primers do DNA/genética , Feminino , Predisposição Genética para Doença , Humanos , Masculino , Razão de Chances , Peptídeos/química , Peptídeos/genética , Polimorfismo Genético , Transfecção
19.
Endocr Dev ; 10: 15-28, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17684387

RESUMO

In many instances, the pathophysiology of thyroid dysgenesis (TD) remains as yet unclear and until relatively recently the disorder was usually regarded as occurring in a sporadic manner. However, over the past few years, a small but significant proportion of familial cases has been identified (2%) through the study of subjects with congenital hypothyroidism and more recent work has revealed an even higher proportion of familial TD in both symptomatic or asymptomatic individuals (7.9%). Together, these studies strongly point to a significant genetic component of this disorder. Moreover, detailed observations of members affected by different types of TD in the same family suggest that TD could be an entity with a common underlying mechanism for all the etiological groups. To date, molecular genetic studies have implicated four genes in thyroid development and some mutations have been reported in affected subjects. Three of these encode transcription factors while the forth encodes the thyrotropin hormone receptor. However, their involvement in the general TD population remains questionable, as only a few mutations have been reported so far and as linkage analysis has demonstrated the relevance of other genes. Therefore, further work is required to fully understand the pathophysiology of TD.


Assuntos
Disgenesia da Tireoide/genética , Hipotireoidismo Congênito/genética , Humanos , Linhagem , Disgenesia da Tireoide/classificação , Glândula Tireoide/embriologia
20.
Mol Cell Endocrinol ; 434: 69-80, 2016 10 15.
Artigo em Inglês | MEDLINE | ID: mdl-27302892

RESUMO

Mast cells are present in the human adult adrenal with a potential role in the regulation of aldosterone secretion in both normal cortex and adrenocortical adenomas. We have investigated the human developing adrenal gland for the presence of mast cells in parallel with steroidogenic enzymes profile and serotonin signaling pathway. RT-QPCR and immunohistochemical studies were performed on adrenals at 16-41 weeks of gestation (WG). Tryptase-immunopositive mast cells were found from 18 WG in the adrenal subcapsular layer, close to 3ßHSD- and CYP11B2-immunoreactive cells, firstly detected at 18 and 24 WG, respectively. Tryptophan hydroxylase and serotonin receptor type 4 expression increased at 30 WG before the CYP11B2 expression surge. In addition, HDL and LDL cholesterol receptors were expressed in the subcapsular zone from 24 WG. Altogether, our findings suggest the implication of mast cells and serotonin in the establishment of the mineralocorticoid synthesizing pathway during fetal adrenal development.


Assuntos
Glândulas Suprarrenais/embriologia , Aldosterona/metabolismo , Mastócitos/citologia , Serotonina/metabolismo , Transdução de Sinais , 3-Hidroxiesteroide Desidrogenases/genética , 3-Hidroxiesteroide Desidrogenases/metabolismo , Glândulas Suprarrenais/citologia , Glândulas Suprarrenais/metabolismo , Citocromo P-450 CYP11B2/genética , Citocromo P-450 CYP11B2/metabolismo , Feminino , Regulação da Expressão Gênica no Desenvolvimento , Humanos , Lipoproteínas HDL/genética , Lipoproteínas HDL/metabolismo , Mastócitos/metabolismo , Gravidez , Receptores de LDL/genética , Receptores de LDL/metabolismo , Receptores de Lipoproteínas/genética , Receptores de Lipoproteínas/metabolismo , Receptores de Serotonina/genética , Receptores de Serotonina/metabolismo , Triptases/genética , Triptases/metabolismo , Triptofano Hidroxilase/genética , Triptofano Hidroxilase/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA